Join University of Minnesota Cardiology Fellow Rahul Singh, MD for a talk on Coronary Intravascular Imaging and Physiologic Testing as part of our ongoing FIT Lecture Series.
Save the Date! Cardiology Fellows-in-Training will have the opportunity to hear from some of Minnesota’s top cardiologists about their real-world experiences during the transition from training to practice. We will have a panel discussion for approximately 90 minutes, with time outside of that for questions and networking.
Anemia in CKD is associated with poor CV outcomes, increased risk of CKD progression, decreased health-related quality of life (HRQOL), and increased healthcare resource utilization. Erythropoiesis-stimulating agents have been the standard of care for treating anemia in CKD but are associated with CV safety concerns; other therapies include red blood cell transfusions and iron administration, but each potentially has severe adverse events.
Hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) are promising novel agents in development for treating CKD-associated anemia. These oral agents increase endogenous erythropoietin production, improve iron absorption and mobilization, and decrease hepcidin production in the liver.
Anemia in Patients with CVD and CKD: Current Management and Potential Role of HIF-PHIs will provide cardiologists with information about the etiology of anemia in CKD, the effects on CV disease, HRQOL, and function, advantages and limitations of current management strategies, and the efficacy and safety data for HIF-PHIs in late-stage development for the management of CKD-related anemia.
At the conclusion of this activity, participants should be able to:
Erin Michos, MD, MHS
Associate Professor of Medicine
Division of Cardiology
Johns Hopkins School of Medicine
Matthew Weir, MD
Professor and Chief
Division of Nephrology
Department of Medicine
University of Maryland School of Medicine
Jointly provided by USFH and Rockpointe.
This educational activity is supported by an educational grant from GlaxoSmithKline.
Join us the second Tuesday of each month for our ongoing Fellows in Training (FIT) Lecture Series. On Tuesday, September 13th from 6-8 PM Iulia-Maria Tulai, M.D., Cardiology Fellow at the Minneapolis Heart Institute Foundation & Hennepin Healthcare, will present a talk on mitral valve prolapse.
This event is free, but registration is required. Register here and mark your calendars for the second Tuesday of every month to join us for future lectures.
The 2022 Midwest Cardiovascular Forum will include a poster contest from 4:30-6:00pm on Saturday, October 29th at the Royal Sonesta Downtown Minneapolis.
After a two-year hiatus, the Midwest Cardiovascular Forum is returning this fall for a 1.5-day conference exploring the latest in cardiology! Sessions include topics for seasoned cardiologists, fellows-in-training, and cardiovascular team members. Join us in downtown Minneapolis from October 29-30.
Visit the Midwest Cardiovascular Forum web page for more details, and mark your calendar to attend.
ASCVD Risk Estimator Plus is an update to the American College of Cardiology ASCVD Risk Estimator that uses recent science and user feedback to help a clinician and patient build a customized risk lowering plan by estimating and monitoring change in 10 year ASCVD risk.
Use the app to:
Choose specific sections, or download the entire PDF Guide.
Preamble
Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines with recommendations to improve cardiovascular health. These guidelines, which are based on systematic methods to evaluate and classify evidence, provide a foundation for the delivery of quality cardiovascular care. The ACC and AHA sponsor the development and publication of clinical practice guidelines without commercial support, and members volunteer their time to the writing and review efforts. Guidelines are official policy of the ACC and AHA. For some guidelines, the ACC and AHA partner with other organizations.
Intended Use
Clinical practice guidelines provide recommendations applicable to patients with or at risk of developing cardiovascular disease. The focus is on medical practice in the United States, but these guidelines are relevant to patients throughout the world. Although guidelines may be used to inform regulatory or payer decisions, the intent is to improve quality of care and align with patients’ interests. Guidelines are intended to define practices meeting the needs of patients in most, but not all, circumstances, and should not replace clinical judgment.
*The following guiding principles and member guidance regarding maternal cardiovascular care are intended help members as they continue to provide the highest levels of care to patients following the recent Supreme Court decision on Dobbs vs. Jackson. They can also be accessed on ACC.org.
Background:
The ACC has long advocated for patients engaging with their doctor and the cardiovascular care team about their heart health and related risks. Shared decision-making is an essential tool in helping to navigate the risks and benefits of all treatment options, taking into account the latest science and medical evidence, social determinants of health, emphasis on health equity, and the patient’s own beliefs and goals.
While the ACC has no official policy on abortion, clinical practice guidelines and other clinical guidance tools address the dangers of pregnancy in certain patient populations at higher risk of death or serious cardiac events. As such, the College is deeply concerned about the potential implications of the Supreme Court decision regarding Dobbs vs. Jackson on the ability of patients and clinicians to engage in important shared discussions about maternal health, or to remove previously available health care options, especially given the alarming maternal health crisis in the U.S.
Similar to topics like gun violence that impact the broader medical community and the patients we serve, the ACC will continue to work with the larger House of Medicine to address specific laws and policies as they move forward that would threaten or criminalize patient-clinician discussions regarding maternal cardiovascular care.
Guiding Principles:
ACC’s mission is to transform cardiovascular care and improve heart health. We are patient-centered in our decisions and value teamwork, collaboration, professionalism and excellence.
Member Guidance:
Join us the second Tuesday of each month for our ongoing Fellows in Training (FIT) Lecture Series. On Tuesday, August 9th from 6-8pm Kathryn F. Larson, M.D., Chief Fellow in the Division of Cardiology at Mayo Clinic will present a talk on Pericarditis.
This event is free, but registration is required. Register here and mark your calendars for the second Tuesday of every month to join us for future lectures.
Using a case-based format, we will review the basics of diagnosis, ancillary testing, and therapeutics for pericarditis. The talk will include a discussion of the 2015 ESC Guidelines on pericardial disease, as well as a brief overview of key pivotal trials in the management of pericarditis (both initial episodes and recurrence).
While listening to Julio Palmaz speak at a conference in Scottsdale, Arizona in February 1989, Henning Rud Andersen was inspired to concept implanting heart valves percutaneously. Within 3 months, Dr. Andersen made and implanted the first transcatheter heart valve in an animal model. Today, TAVI is the main treatment of severe aortic stenosis in many parts of the world. Join Drs. Mohamad Alkhouli and David R. Holmes for a virtual conversation with Dr. Andersen about his extraordinary journey with TAVI.
Moderators: Mohamad Alkhouli MD, FACC and David Holmes MD
Guest: Henning Rud Andersen MD
